Jennison Associates
IMDZ

Jennison Associates’s Immune Design Corp. IMDZ Stock Holding History

Jennison Associates’s Portfolio IMDZ Stock Details IMDZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-168,004
Closed -$2.18M – 682
2016
Q1 		$2.18M Sell
168,004
-35,448
-17% -$409K ﹤0.01% 526
2015
Q4 		$4.08M Buy
203,452
+769
+0.4% +$13.3K ﹤0.01% 521
2015
Q3 		$2.47M Buy
202,683
+1,224
+0.6% +$22.9K ﹤0.01% 588
2015
Q2 		$4.16M Buy
+201,459
New +$4.76M ﹤0.01% 548

Other funds holding IMDZ

PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates's IMDZ Position: Q2 2016 in Review

Jennison Associates sold out of Immune Design Corp. (IMDZ) in Q2 2016, closing a stake of 168,004 shares — an estimated $2.18M sold.

Jennison Associates first reported a position in IMDZ in Q2 2015 and held it in 4 quarters. The position peaked at $4.16M in Q2 2015. 60 funds tracked by Wall St. Rank hold IMDZ as of Q2 2016.

  • Jennison Associates reported no remaining Immune Design Corp. position as of Q2 2016 after selling out during the quarter.
  • Jennison Associates sold 168,004 Immune Design Corp. shares in Q2 2016, an estimated $2.18M.
  • Jennison Associates first reported a position in Immune Design Corp. in Q2 2015 and held it in 4 quarters.
  • Jennison Associates's Immune Design Corp. position peaked at $4.16M in Q2 2015.
  • 60 funds tracked by Wall St. Rank held Immune Design Corp. as of Q2 2016.

Based on Jennison Associates's 13F filing for Q2 2016, filed 3 Aug 2016.